GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty (CPP), according to a study presented at ENDO 2025, the annual meeting of the ...

In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is associated with superior weight loss outcomes, according to a study presented at ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx ...

Dietary approaches like intermittent energy restriction, time-restricted eating, and continuous energy restriction can all ...

SAN FRANCISCO -- Age of menarche may provide several insights on long-term cardiometabolic and reproductive health, a ...

New Phase II data presented at ENDO 2025 highlight avexitide’s potential to significantly reduce severe hypoglycemic events ...

Tokyo Governor Yuriko Koike spoke at her regular news briefing on July 11. She was asked about campaign talk about foreign ...

Socially Isolated Older Adults are at 34% Higher Risk of Diabetes: ENDO 2025 StudyA study presented at ENDO 2025, the Endocrine Society’s annual meeting ...

Liverpool transfer news as Arne Slot's men look forward to their pre-season tour of Asia and a match against AC Milan ...

President Ferdinand Marcos Jr., through the Economic and Development Council, has approved a public-private partnership for ...